Erin N Guidry

Title: Erin N Guidry: Innovator in RNA Interference Technology

Introduction

Erin N Guidry is a prominent inventor based in Kenilworth, NJ (US). She has made significant contributions to the field of RNA interference (RNAi) technology. With a total of 2 patents, her work focuses on the development of innovative nucleic acid molecules.

Latest Patents

Erin's latest patents include groundbreaking inventions related to short interfering nucleic acid (siNA) molecules. One of her notable patents describes siNA molecules containing a 2' internucleoside linkage. This invention relates to RNAi molecules and compositions that comprise a 2' internucleoside linkage connecting the nucleotide at position 1 and the nucleotide at position 2 at the 5' end of the antisense strand. The invention specifically addresses single- and double-stranded siNA molecules capable of mediating RNA interference. These molecules include 5' modified nucleotides that may feature various modifications, including the 2' internucleoside linkage. Additionally, the patent discusses the use of 5' modified nucleotides as reagents to generate RNAi molecules and methods for utilizing these innovative RNAi molecules.

Career Highlights

Throughout her career, Erin has worked with notable companies in the biotechnology sector. She has been associated with Sirna Therapeutics, Inc. and Merck Sharp & Dohme Corporation. Her experience in these organizations has contributed to her expertise in RNAi technology and molecular biology.

Collaborations

Erin has collaborated with esteemed colleagues, including Wonsuk Chang and Matthew G Stanton. These partnerships have further enhanced her research and development efforts in the field of RNA interference.

Conclusion

Erin N Guidry is a distinguished inventor whose work in RNA interference technology has paved the way for advancements in molecular biology. Her innovative patents and collaborations reflect her commitment to scientific progress and innovation.